This cannabinoids mental health meta-analysis reviews 54 randomized trials across psychiatric and substance use conditions. It identifies modest benefits in insomnia, Tourette syndrome, ASD traits, and cannabis withdrawal, but with low certainty. For most mental health conditions, the evidence does not support routine prescribing.
Taylor et al – 2017 – Comparison of cannabinoids in hair with self-reported cannabis consumption in heavy light
Taylor et al – 2017 – Comparison of cannabinoids in hair with self-reported cannabis consumption in heavy light
Cannabis and sleep, what patients get wrong and what clinicians should explain #2
A concept focused on common misunderstandings in sleep care and evidence-based cannabinoid framing.
D.C. Tightens Cannabis Ads and Virginia Moves Toward Adult-Use Sales
The DMV cannabis landscape is evolving fast: D.C.: Tightening ads — limiting youth exposure, content rules Virginia: Building retail framework — July applications, Nov sales One jurisdiction refining. One building from scratch. Both navigating the same federal uncertainty. Progress looks different everywhere. But it’s all progress. Outlaw Report covers two significant developments in the DMV cannabis landscape. Washington D.C.